Literature DB >> 30763536

Phage Therapy: A Renewed Approach to Combat Antibiotic-Resistant Bacteria.

Kaitlyn E Kortright1, Benjamin K Chan2, Jonathan L Koff3, Paul E Turner4.   

Abstract

Phage therapy, long overshadowed by chemical antibiotics, is garnering renewed interest in Western medicine. This stems from the rise in frequency of multi-drug-resistant bacterial infections in humans. There also have been recent case reports of phage therapy demonstrating clinical utility in resolving these otherwise intractable infections. Nevertheless, bacteria can readily evolve phage resistance too, making it crucial for modern phage therapy to develop strategies to capitalize on this inevitability. Here, we review the history of phage therapy research. We compare and contrast phage therapy and chemical antibiotics, highlighting their potential synergies when used in combination. We also examine the use of animal models, case studies, and results from clinical trials. Throughout, we explore how the modern scientific community works to improve the reliability and success of phage therapy in the clinic and discuss how to properly evaluate the potential for phage therapy to combat antibiotic-resistant bacteria.
Copyright © 2019 Elsevier Inc. All rights reserved.

Entities:  

Mesh:

Year:  2019        PMID: 30763536     DOI: 10.1016/j.chom.2019.01.014

Source DB:  PubMed          Journal:  Cell Host Microbe        ISSN: 1931-3128            Impact factor:   21.023


  180 in total

1.  A Dutch Case Report of Successful Treatment of Chronic Relapsing Urinary Tract Infection with Bacteriophages in a Renal Transplant Patient.

Authors:  Saskia Kuipers; Mike M Ruth; Mike Mientjes; Ruud G L de Sévaux; Jakko van Ingen
Journal:  Antimicrob Agents Chemother       Date:  2019-12-20       Impact factor: 5.191

2.  Tailored Antibacterials and Innovative Laboratories for Phage (Φ) Research: Personalized Infectious Disease Medicine for the Most Vulnerable At-Risk Patients.

Authors:  Austen L Terwilliger; Carmen Gu Liu; Sabrina I Green; Justin R Clark; Keiko C Salazar; Haroldo Hernandez Santos; Emmaline R Heckmann; Barbara W Trautner; Robert F Ramig; Anthony W Maresso
Journal:  Phage (New Rochelle)       Date:  2020-06-16

Review 3.  Phage therapy as strategy to face post-antibiotic era: a guide to beginners and experts.

Authors:  Sabrina Royer; Aléxia Pinheiro Morais; Deivid William da Fonseca Batistão
Journal:  Arch Microbiol       Date:  2021-01-20       Impact factor: 2.552

4.  Coevolutionary phage training leads to greater bacterial suppression and delays the evolution of phage resistance.

Authors:  Joshua M Borin; Sarit Avrani; Jeffrey E Barrick; Katherine L Petrie; Justin R Meyer
Journal:  Proc Natl Acad Sci U S A       Date:  2021-06-08       Impact factor: 11.205

Review 5.  Precision Medicine Goes Microscopic: Engineering the Microbiome to Improve Drug Outcomes.

Authors:  Kathy N Lam; Margaret Alexander; Peter J Turnbaugh
Journal:  Cell Host Microbe       Date:  2019-07-10       Impact factor: 21.023

6.  Lytic bacteriophages facilitate antibiotic sensitization of Enterococcus faecium.

Authors:  Gregory S Canfield; Anushila Chatterjee; Juliel Espinosa; Mihnea R Mangalea; Emma K Sheriff; Micah Keidan; Sara W McBride; Bruce D McCollister; Howard C Hang; Breck A Duerkop
Journal:  Antimicrob Agents Chemother       Date:  2021-03-01       Impact factor: 5.191

7.  Profile of Paul E. Turner.

Authors:  Jennifer Viegas
Journal:  Proc Natl Acad Sci U S A       Date:  2020-08-03       Impact factor: 11.205

Review 8.  Extracellular Vesicle Biogenesis and Functions in Gram-Positive Bacteria.

Authors:  Paul Briaud; Ronan K Carroll
Journal:  Infect Immun       Date:  2020-11-16       Impact factor: 3.441

9.  Colistin-resistance-mediated bacterial surface modification sensitizes phage infection.

Authors:  Guijuan Hao; Annie I Chen; Ming Liu; Haijian Zhou; Marisa Egan; Xiaoman Yang; Biao Kan; Hui Wang; Mark Goulian; Jun Zhu
Journal:  Antimicrob Agents Chemother       Date:  2019-09-30       Impact factor: 5.191

10.  Decoding the molecular properties of mycobacteriophage D29 Holin provides insights into Holin engineering.

Authors:  Varun Rakeshbhai Bavda; Aditi Yadav; Vikas Jain
Journal:  J Virol       Date:  2021-02-24       Impact factor: 5.103

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.